Literature DB >> 24596423

Five-year relative survival rate of liver cancer in the USA, Europe and Japan.

Kota Katanoda, Tomohiro Matsuda.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24596423     DOI： 10.1093/jjco/hyu025

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN： 0368-2811            Impact factor:   3.019


× No keyword cloud information.
  8 in total

1.  Lentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro.

Authors:  Ze-Ya Pan; Yun Yang; Hao Pan; Jin Zhang; Hui Liu; Yuan Yang; Gang Huang; Lei Yin; Jian Huang; Wei-Ping Zhou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Identification of hub genes associated with obesity-induced hepatocellular carcinoma risk based on integrated bioinformatics analysis.

Authors:  Hamid Ceylan
Journal:  Med Oncol       Date:  2021-04-26       Impact factor: 3.064

3.  LINC00922 promotes the proliferation, migration, invasion and EMT process of liver cancer cells by regulating miR-424-5p/ARK5.

Authors:  Zhiyu Ye; Qikuan He; Qiaona Wang; Yunshou Lin; Kenan Cen; Xiaogang Chen
Journal:  Mol Cell Biochem       Date:  2021-06-07       Impact factor: 3.396

4.  Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis.

Authors:  Shilian Chen; Yaqin Zhang; Xuan Wu; Chaoyang Zhang; Guancheng Li
Journal:  Can J Gastroenterol Hepatol       Date:  2018-10-15

5.  The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.

Authors:  Chaoyang Zhang; Li Peng; Yaqin Zhang; Zhaoyang Liu; Wenling Li; Shilian Chen; Guancheng Li
Journal:  Med Oncol       Date:  2017-04-21       Impact factor: 3.064

6.  Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.

Authors:  Xiaoqing Zheng; Weiwei Ma; Ruoxuan Sun; Hanwei Yin; Fei Lin; Yuxi Liu; Wei Xu; Huihui Zeng
Journal:  Redox Biol       Date:  2017-09-22       Impact factor: 11.799

7.  Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma.

Authors:  Po-Yee Chung; Pik-Ling Lam; Yuan-Yuan Zhou; Jessica Gasparello; Alessia Finotti; Adriana Chilin; Giovanni Marzaro; Roberto Gambari; Zhao-Xiang Bian; Wai-Ming Kwok; Wai-Yeung Wong; Xi Wang; Alfred King-Yin Lam; Albert Sun-Chi Chan; Xingshu Li; Jessica Yuen-Wuen Ma; Chung-Hin Chui; Kim-Hung Lam; Johnny Cheuk-On Tang
Journal:  Cells       Date:  2018-10-22       Impact factor: 6.600

8.  Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma.

Authors:  Jinyu Zhu; Bufu Tang; Jie Li; Yueli Shi; Minjiang Chen; Xiuling Lv; Miaomiao Meng; Qiaoyou Weng; Nannan Zhang; Kai Fan; Min Xu; Jiansong Ji
Journal:  Aging (Albany NY)       Date:  2020-05-06       Impact factor: 5.682
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.